Literature DB >> 23542051

Computational modeling of tuberculous meningitis reveals an important role for tumor necrosis factor-α.

M El-Kebir1, M van der Kuip, A M van Furth, D E Kirschner.   

Abstract

Tuberculosis is a global health issue with annually about 1.5 million deaths and 2 billion infected people worldwide. Extra-pulmonary tuberculosis comprises 13% of all cases of which tuberculous meningitis is the most severe. It has a high mortality and is often diagnosed once irreversible neurological damage has already occurred. Development of diagnostic and treatment strategies requires a thorough understanding of the pathogenesis of tuberculous meningitis. This disease is characterized by the formation of a cerebral granuloma, which is a collection of immune cells that attempt to immunologically restrain, and physically contain bacteria. The cytokine tumor necrosis factor-α is known for its important role in granuloma formation. Because traditional experimental animal studies exploring tuberculous meningitis are difficult and expensive, another approach is needed to begin to address this important and significant disease outcome. Here, we present an in silico model capturing the unique immunological environment of the brain that allows us to study the key mechanisms driving granuloma formation in time. Uncertainty and sensitivity analysis reveals a dose-dependent effect of tumor necrosis factor-α on bacterial load and immune cell numbers thereby influencing the onset of tuberculous meningitis. Insufficient levels result in bacterial overgrowth, whereas high levels lead to uncontrolled inflammation being detrimental to the host. These findings have important implications for the development of immuno-modulating treatment strategies for tuberculous meningitis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542051      PMCID: PMC3821557          DOI: 10.1016/j.jtbi.2013.03.008

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  56 in total

1.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

2.  Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability.

Authors:  Mohammad Fallahi-Sichani; JoAnne L Flynn; Jennifer J Linderman; Denise E Kirschner
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

3.  Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation.

Authors:  Mohammad Fallahi-Sichani; Mohammed El-Kebir; Simeone Marino; Denise E Kirschner; Jennifer J Linderman
Journal:  J Immunol       Date:  2011-02-14       Impact factor: 5.422

4.  Turnover of resident microglia in the normal adult mouse brain.

Authors:  L J Lawson; V H Perry; S Gordon
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

5.  Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis.

Authors:  Sanjay K Jain; Maneesh Paul-Satyaseela; Gyanu Lamichhane; Kwang S Kim; William R Bishai
Journal:  J Infect Dis       Date:  2006-03-28       Impact factor: 5.226

6.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

Review 7.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system.

Authors:  L Tsenova; A Bergtold; V H Freedman; R A Young; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study.

Authors:  Johan F Schoeman; Priscilla Springer; Anita Janse van Rensburg; Sonja Swanevelder; Willem A Hanekom; Patrick A J Haslett; Gilla Kaplan
Journal:  J Child Neurol       Date:  2004-04       Impact factor: 1.987

10.  Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents.

Authors:  M Estée Török; Duc Bang Nguyen; Thi Hong Chau Tran; Thi Bich Yen Nguyen; Guy E Thwaites; Thi Quy Hoang; Huy Dung Nguyen; Tinh Hien Tran; Tran Chinh Nguyen; Hoang Thi Thanh Hoang; Marcel Wolbers; Jeremy J Farrar
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

View more
  3 in total

1.  A hypothetical astrocyte-microglia lactate shuttle derived from a 1H NMR metabolomics analysis of cerebrospinal fluid from a cohort of South African children with tuberculous meningitis.

Authors:  Shayne Mason; A Marceline van Furth; Lodewyk J Mienie; Udo F H Engelke; Ron A Wevers; Regan Solomons; Carolus J Reinecke
Journal:  Metabolomics       Date:  2014-10-11       Impact factor: 4.290

2.  Deciphering Genetic Susceptibility to Tuberculous Meningitis.

Authors:  Haiko Schurz; Brigitte Glanzmann; Nicholas Bowker; Ronald van Toorn; Regan Solomons; Johan Schoeman; Paul D van Helden; Craig J Kinnear; Eileen G Hoal; Marlo Möller
Journal:  Front Neurol       Date:  2022-03-25       Impact factor: 4.003

3.  Immunological recovery in patients with pulmonary tuberculosis after intensive phase treatment.

Authors:  Xuejiao Luo; Furong Wu; Jun Ma; Heping Xiao; Haiyan Cui
Journal:  J Int Med Res       Date:  2018-05-13       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.